Cargando…
Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
Autores principales: | Gandhi, Monica, Nachega, Jean, Miller, Veronica, Wilkin, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338993/ https://www.ncbi.nlm.nih.gov/pubmed/37439071 http://dx.doi.org/10.1002/jia2.26093 |
Ejemplares similares
-
Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021) -
Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023) -
Rapid initiation of antiretroviral therapy for people living with HIV
por: Mateo‐Urdiales, Alberto, et al.
Publicado: (2019) -
Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All
por: Ford, Nathan, et al.
Publicado: (2018) -
HIV care cascade and sustainable wellbeing of people living with HIV in context
por: Seckinelgin, Hakan
Publicado: (2019)